PANACEA cough sound-based diagnosis of COVID-19 for the DiCOVA 2021 Challenge

The COVID-19 pandemic has led to the saturation of public health services worldwide. In this scenario, the early diagnosis of SARS-Cov-2 infections can help to stop or slow the spread of the virus and to manage the demand upon health services. This is especially important when resources are also being stretched by heightened demand linked to other seasonal diseases, such as the flu. In this context, the organisers of the DiCOVA 2021 challenge have collected a database with the aim of diagnosing COVID-19 through the use of coughing audio samples. This work presents the details of the automatic system for COVID-19 detection from cough recordings presented by team PANACEA. This team consists of researchers from two European academic institutions and one company: EURECOM (France), University of Granada (Spain), and Biometric Vox S.L. (Spain). We developed several systems based on established signal processing and machine learning methods. Our best system employs a Teager energy operator cepstral coefficients (TECCs) based frontend and Light gradient boosting machine (LightGBM) backend. The AUC obtained by this system on the test set is 76.31% which corresponds to a 10% improvement over the official baseline.

Silent Speech Interfaces for Speech Restoration: A Review

This review summarises the status of silent speech interface (SSI) research. SSIs rely on non-acoustic biosignals generated by the human body during speech production to enable communication whenever normal verbal communication is not possible or not desirable. In this review, we focus on the first case and present latest SSI research aimed at providing new alternative and augmentative communication methods for persons with severe speech disorders. SSIs can employ a variety of biosignals to enable silent communication, such as electrophysiological recordings of neural activity, electromyographic (EMG) recordings of vocal tract movements or the direct tracking of articulator movements using imaging techniques. Depending on the disorder, some sensing techniques may be better suited than others to capture speech-related information. For instance, EMG and imaging techniques are well suited for laryngectomised patients, whose vocal tract remains almost intact but are unable to speak after the removal of the vocal folds, but fail for severely paralysed individuals. From the biosignals, SSIs decode the intended message, using automatic speech recognition or speech synthesis algorithms. Despite considerable advances in recent years, most present-day SSIs have only been validated in laboratory settings for healthy users. Thus, as discussed in this paper, a number of challenges remain to be addressed in future research before SSIs can be promoted to real-world applications. If these issues can be addressed successfully, future SSIs will improve the lives of persons with severe speech impairments by restoring their communication capabilities.